Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

INTERIM REPORT Period from January 2019 to March 2019

2019 FIRST QUARTER (Jan-Mar) · Net sales of products KSEK 1,470 (0) · Gross profit KSEK 802 (0), Gross margin 55% (0%) · Operating loss KSEK -3,185 (-2,756)  · Loss per share SEK -0.04 (-0.06)IMPORTANT EVENTS DURING THE PERIOD · On January 10th, 2019 the Company announced that its self-care product for the treatment of vaginal atrophy and dryness - VagiVital® - has been approved for sale through Apoteket AB’s retail shops and on-line shop, by Apoteket Hjärtat for sale in its on-line pharmacy shop, and by Apoteksgruppen for sales in approximately forty of its franchise

Interim Report January – March 2019

Order intake continues to improve and several new customers Q1 2019 · Net sales for the period amounted to SEK 10.7 (1.9) million and earnings to SEK -16.3 (-21.3) million, which corresponds to earnings per share of SEK -0.25 (-0.64).   · Gross profit amounted to SEK -2.6 million, which is an improvement of SEK 4.7 million compared to the corresponding period in 2018.  · Cash and cash equivalents as at March 31 amounted to SEK 43.1 (48.3) million.  · During the period January 28 February 15, 2019, the Company conducted a new issue that resulted in a capital

First day of the subscription period in Episurf Medical’s Rights Issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE UNITED KINGDOM, JAPAN, NEW ZEALAND, SINGAPORE, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFULToday is the first day of subscription period in Episurf Medical AB’s (publ) (“Episurf Medical” or the “Company”) Rights Issue with preferential right for existing shareholders. ”An increasing number of our customers testify that the treatment gap is closing – thanks to the Episealer©-implant.

Dignitana AB Publishes Q1 2019 Interim Report

Results and financial position Significant events during the period · Sales and other income for the period amounted to 10,106 TSEK, $1,102 KUSD, an increase of 69 percent compared to the same period in 2018 and a15 percent quarter over quarter growth compared to fourth quarter 2018. · EBITDA amounted to (2,799) TSEK, ($305) KUSD, a 59 percent improvement compared to the same period in 2018. · Contracts were signed for 22 locations globally, bringing the total number of sites in the U.S. to 125 in 29 states at the close of first quarter. · Dignitana announced receipt of CE

Year-end report 1 April 2018 - 31 March 2019

FOURTH QUARTER (1 JANUARY - 31 MARCH 2019) · Net sales increased by 35 percent and amounted to SEK 2,864 million (2,121). · Operating profit before amortisation of intangible non-current assets (EBITA) increased by 40 percent and amounted to SEK 309 million (221) corresponding to an EBITA-margin of 10.8 percent (10.4). · Operating profit increased by 42 percent and amounted to SEK 260 million (184) corresponding to an operating margin of 9.1 percent (8.7). · Profit after tax increased by 35 percent and amounted to SEK 180 million (133) and earnings per share before dilution

New study confirms non-recycled paper is better for the climate

When produced where the environmental impact of producing electricity is low, and where the forest is sustainably managed, paper from fresh fibres has lower environmental impact than paper from recycled fibres. That’s the conclusion of a new life cycle study made by IVL, Swedish Environmental Research Institute.The study uses a Life Cycle Assessment (LCA) methodology, comparing 100% fresh fibre-based paper produced at Holmen Paper in Sweden with 100% recycled-based paper produced with German production conditions. The study shows that paper based on fresh fibre has a lower environmental

Report for the first quarter 2019

Financial and operating highlights 1Q 2019 (1Q 2018 in brackets): · Operating revenues were NOK 1 687 million (NOK 1 411 million) · EBITDA (operating result before depreciation, impairment, result from associates, finance and tax) was NOK 251 million (NOK 192 million) · Depreciation was NOK 229 million (NOK 246 million) · EBIT (operating result) was NOK 22 million (NOK -54 million) · Net result after tax from continuing operations was NOK -200 million (NOK -167 million) Renewable energy · EBITDA NOK 384 mill. (NOK 283 mill.) · Total generation up 12% · Year on

HIDDN: Financial results for the first quarter of 2019

(Oslo, 15 May 2019) Hiddn Solutions ASA (Hiddn, OSE: HIDDN) reported total revenues of NOK 3.7 million in the first quarter 2019, down from NOK 5.5 million in the corresponding quarter of 2018. The operating revenue in the first quarter of 2019 is primarily due to longer than expected lead times on critical components, including delays due to Chinese New Year and consequently deferred production start-up of new product line. Loss before tax was NOK 8.9 million compared to a loss before tax of NOK 11.5 million in first quarter of 2018. The company has now met the criteria for capitalization

NENT Group appoints Head of People and Culture

· Sahar Kupersmidt appointed as SVP & Head of People and Culture · New function responsible for NENT Group’s talent attraction and retention, competence and leadership development Nordic Entertainment Group (NENT Group) has appointed Sahar Kupersmidt as Senior Vice President & Head of People and Culture. The new People and Culture function will drive NENT Group’s work to attract, motivate and retain the best people in the business, while also focusing on the implementation of the Group’s new values and continued development of the company’s culture. The new role of Head of People

Fully financed Phase III program for Mangoral through the IPO

Ascelia Pharma AB (publ) (ticker: ACE) today announced that its interim report for the period January-March 2019 is now available on the company’s website: https://www.ascelia.com/tag/reports-presentations/IMPORTANT EVENTS IN THE PERIOD · IPO of SEK 200 million · More than 6,000 new shareholders in the IPO – both institutional and private · Fully financed Phase III program for Mangoral IMPORTANT EVENTS AFTER THE PERIOD · Encouraging results from Oncoral’s Phase I combination study with oral capecitabine · IPO overallotment utilised raising SEK 22 million ·

Peter Revay appointed as a member of Delete's Management Team and the Country Manager of Delete Sweden

Delete Group Oyj | Stock Exchange Release, 15 May 2019 at 9:00 AM (EEST) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PETER REVAY APPOINTED AS A MEMBER OF DELETE’S MANAGEMENT TEAM AND THE COUNTRY MANAGER OF DELETE SWEDEN Peter Revay has been appointed as a member of Delete Group’s management team and the new Country Manager of Delete Sweden. He will start in August 2019. Previously, Revay has been the CEO of Tunga Lyft AB, a company

BIMobject: Interim Report January – March 2019

The complete report is available on the Company’s website info.bimobject.com. First quarter 2019 ·  Billing increased by 58 percent to SEK 30 (19) million. ·  The Group’s net sales increased by 52 percent to SEK 33 (21) million. The distribution between projects and web services (subscriptions) was 34/66 (44/56) percent. ·  The Group’s operating profit/loss amounted to SEK -30 (-19) million. ·  Basic earnings per share amounted to SEK -0.23 (-0.43). ·  Cash flow from operating activities was SEK -25 (0) million. ·  The accumulated number of users in thousands

Eastnine AB publishes Q1 2019 Report

January - March: · Rental income increased by 48 percent to EUR 2,947k (1,993) primarily due to acquisitions and the completion of the third tower in 3Burės in Vilnius. Comparable rental income decreased by 11 percent due to reduced occupancy. · Occupancy rate was 92.0 percent (99.6). · Net operating income increased to EUR 2,689k (1,431). · Profit from property management increased to EUR 1,279k (151). · Other unrealised value changes amounted to EUR 3,802k (-97) of which EUR 3,669k (-1,089) is attributable to Melon Fashion Group, EUR 789k (1,019) to Real Estate Funds and

Interim report January - March 2019

Mölndal, May 15, 2019 – Vicore Pharma Holding (publ) publishes the interim report for the first quarter 2018.Important events during the first quarter · In January, the directed share issue of approximately 160 MSEK was approved by an Extraordinary General Meeting. The total number of shares after the share issue amounts to 42,374,714. Important events after the period · Vicore Pharma announced on April 23 that it has selected the disease diffuse systemic sclerosis (dSSc) as the second indication for its lead program VP01 (C21). It complements the primary indication, idiopathic

NENT Group appoints CEO of Viasat Consumer

· Jonas Gustafsson appointed SVP & CEO of Viasat Consumer · New organisation comprises NENT Group’s satellite and broadband TV consumer offerings Nordic Entertainment Group (NENT Group) has appointed Jonas Gustafsson as Senior Vice President & CEO of Viasat Consumer, a new NENT Group operating unit. Viasat is one of the most recognised entertainment brands in the Nordic region and the new organisation comprises Viasat’s satellite and broadband TV consumer offerings. The new Viasat Consumer organisation will focus on aligning and realising the full commercial potential of NENT Group’

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions   15 May 2019 at 09:00 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Ståhlberg Tuukka Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Kärpänen Milla Position: Chief Financial Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20190513160234_3 _______________________________

KAMUX OYJ - Managers' Transactions

Kamux Corporation   Managers’ Transactions   15 May 2019 at 9:00 KAMUX OYJ - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: INKEROINEN MIKKO-HEIKKI Position: Other senior manager (X) Legal person Issuer: KAMUX OYJ LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20190514090241_3 ____________________________________________ Transaction date: 2019-05-13 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN:

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions   15 May 2019 at 9:00 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Olli Kilpi Position: Other senior manager Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20190514104722_2 ____________________________________________ Transaction date: 2019-05-14 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000206750 Nature of the

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions   15 May 2019 at 9:00 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Ståhlberg Kaarlo Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Kärpänen Milla Position: Chief Financial Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20190514144916_2 ________________________________

Tradedoubler Interim Report January - March 2019

The first quarter January – March 2019 · Net sales amounted to SEK 306 M (288), an increase of 7% or 2% adjusted for changes in exchange rates. · Gross profit was SEK 66 M (65), an increase of 1% or a decrease of 3% adjusted for changes in exchange rates. Gross margin was 21.5% (22.6). · Operating costs excluding depreciation and change related items were SEK 53 M (58), a decrease of 9% or 11% adjusted for changes in exchange rates. · EBITDA amounted to SEK 13 M (8). Adjusted for change related items, EBITDA was SEK 13 M (8). · Activated expenses for product development

Summa Equity joins UN SDG Impact Initiative to accelerate SDGs

15 May 2019, Oslo – Summa Equity  today announced their commitment to the United Nations’ SDG Impact initiative  together with Business for Peace, EQT and LGT. This UNDP-led initiative aims to enable private sector investment by providing investors and businesses with the clarity, insights, and tools to support their contributions toward achieving the UN Sustainable Development Goals (SDGs). The Nordic Springboard, of the UNDP SDG Impact Initiative, will be launched at the Business for Peace Summit  in

Gaming Innovation Group: Refinancing of senior bond, investor meetings

Gaming Innovation Group Inc. (GiG) has mandated ABG Sundal Collier and Pareto Securities to organise a series of fixed income investor meetings commencing on Monday 20 May 2019 in connection with a potential refinancing of its senior secured bonds maturing in March 2020. A SEK denominated senior secured bond offering with up to 3.5 years tenor may follow, subject to inter alia market conditions. For further information, please contact: Robin Reed CEO of GIG, robin@gig.com +356 999 903 82 Anna-Lena Åström  Head of IR & Corporate Communications  anna.lena@gig.com +356 796

There are no items matching the current filter
There are no more items matching the current filter
Back to top